ArticleVaccines2021

Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies.

Mohammad Shehab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.